title: Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
abstract: A cDNA clone of the classical swine fever virus (CSFV) strain Alfort/187 [Ruggli N, Tratschin JD, Mittelholzer C, Hofmann MA. Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA. J Virol 1996;70(6):3478-87] was used to construct two E2 deletion mutants lacking either the complete E2 gene or, alternatively, a stretch of 204 nucleotides encoding 68 amino acids located in the C-terminal region of the E2 glycoprotein. The respective in vitro synthesized mutant RNAs replicated in SK-6 cells but no infectious virus was generated. Both replicons could be packaged into virus particles in SK-6 cells constitutively expressing E2 of CSFV. For the resulting CSF virus replicon particles (CSF-VRP) A187-E2del373 and A187-E2del68 titers of 10(6) and 10(7) TCID(50)/ml, respectively, were obtained. Oronasal vaccination with 10(7) TCID(50) of either of the two CSF-VRP protected pigs against a challenge with a lethal dose of CSFV strain Eystrup. In contrast, after intradermal vaccination VRP A187-E2del68 but not VRP A187-E2del373 lacking the complete E2 gene induced a protective immune response. We conclude that E2-complemented CSF-VRP have the potential to be used as live-attenuated non-transmissible oral vaccines for pigs. In addition, our data suggest that E2 of CSFV is dispensable for the induction of mucosal but not of parenteral immunity.
authors.affiliation: Institute of Virology and Immunoprophylaxis, Mittelhäusern, Switzerland. roland.maurer@ivi.admin.ch
authors.forename: Roland
authors.initials: R
authors.lastname: Maurer
authors.forename: Peter
authors.initials: P
authors.lastname: Stettler
authors.forename: Nicolas
authors.initials: N
authors.lastname: Ruggli
authors.forename: Martin A
authors.initials: MA
authors.lastname: Hofmann
authors.forename: Jon-Duri
authors.initials: JD
authors.lastname: Tratschin
mesh_terms: D000281:Administration, Intranasal; D000284:Administration, Oral; D000818:Animals; D002478:Cells, Cultured; D006691:Classical Swine Fever / Q000276:immunology* / Q000517:prevention & control*; D006692:Classical Swine Fever Virus / Q000276:immunology*; D017353:Gene Deletion; D007271:Injections, Intradermal; D012367:RNA, Viral / Q000032:analysis / Q000096:biosynthesis; D013552:Swine; D014614:Vaccines, Synthetic / Q000276:immunology; D014759:Viral Envelope Proteins / Q000235:genetics*; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D012367:RNA, Viral; D014614:Vaccines, Synthetic; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C087086:glycoprotein E2, classical swine fever virus